Protagonist Therapeutics Stock Price on November 7, 2024
| PTGX Stock | USD 45.53 0.93 2.00% |
Below is the normalized historical share price chart for Protagonist Therapeutics extending back to August 11, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protagonist Therapeutics stands at 45.53, as last reported on the 26th of November, with the highest price reaching 48.29 and the lowest price hitting 45.51 during the day.
If you're considering investing in Protagonist Stock, it is important to understand the factors that can impact its price. At this stage we consider Protagonist Stock to be very steady. Protagonist Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0493, which implies the firm had a 0.0493% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Protagonist Therapeutics, which you can use to evaluate the volatility of the company. Please check Protagonist Therapeutics' Risk Adjusted Performance of 0.0547, coefficient of variation of 1609.08, and Semi Deviation of 2.27 to confirm if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, Protagonist Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 375.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 29.8 M in 2024. . At this time, Protagonist Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.39 in 2024, whereas Price To Sales Ratio is likely to drop 20.61 in 2024. Protagonist Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of August 2016 | 200 Day MA 35.8896 | 50 Day MA 45.2514 | Beta 2.163 |
Protagonist |
Sharpe Ratio = 0.0493
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | PTGX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.8 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Protagonist Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protagonist Therapeutics by adding it to a well-diversified portfolio.
Price Book 5.1014 | Enterprise Value Ebitda 14.8105 | Price Sales 8.3803 | Shares Float 44.4 M | Wall Street Target Price 56.375 |
Protagonist Therapeutics Main Headline on 7th of November 2024
Protagonist Therapeutics Inc Q3 2024 Earnings EPS Loss of 0.... by gurufocus.com
Revenue 4.7 million in license and collaboration revenue for Q3 2024, surpassing the previous years 0, driven by the Takeda Collaboration Agreement.Net Los
Protagonist Therapeutics Valuation on November 7, 2024
It is possible to determine the worth of Protagonist Therapeutics on a given historical date. On November 7, 2024 Protagonist was worth 47.43 at the beginning of the trading date compared to the closed value of 47.61. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Protagonist Therapeutics stock. Still, in general, we apply an absolute valuation method to find Protagonist Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Protagonist Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Protagonist Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 48.16 | 48.67 | 46.39 | 47.60 | 1,081,486 | |
11/07/2024 | 47.43 | 48.69 | 46.53 | 47.61 | 427,873 |
| 48.86 | 48.86 | 45.23 | 46.23 | 680,884 |
| Backtest Protagonist Therapeutics | | | Protagonist Therapeutics History | | | Protagonist Therapeutics Valuation | Previous | Next |
Protagonist Therapeutics Trading Date Momentum on November 7, 2024
| On November 08 2024 Protagonist Therapeutics was traded for 46.23 at the closing time. The top price for the day was 48.86 and the lowest listed price was 45.23 . The trading volume for the day was 680.9 K. The trading history from November 8, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.90% . The trading delta at closing time against the current closing price is 13.93% . |
Protagonist Therapeutics Fundamentals Correlations and Trends
By evaluating Protagonist Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Protagonist Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Protagonist financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Protagonist Therapeutics Stock history
Protagonist Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protagonist is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protagonist Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protagonist Therapeutics stock prices may prove useful in developing a viable investing in Protagonist Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56.8 M | 29.8 M | |
| Net Loss | -114.7 M | -108.9 M |
Protagonist Therapeutics Quarterly Net Working Capital |
|
Protagonist Therapeutics Stock Technical Analysis
Protagonist Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Protagonist Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Protagonist Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Protagonist Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Protagonist Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protagonist Therapeutics shares will generate the highest return on investment. By undertsting and applying Protagonist Therapeutics stock market strength indicators, traders can identify Protagonist Therapeutics entry and exit signals to maximize returns
Protagonist Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protagonist Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protagonist Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protagonist to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0547 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0166 | |||
| Treynor Ratio | 0.0976 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.